(Q37785212)

English

Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test

scientific article published on January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Eiji Miyoshi

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Shinichiro Shinzaki

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Kenta Moriwaki

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Hitoshi Matsumoto

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Methods in Enzymology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

478

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

153-164

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular regulation of B lymphocyte response

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological function of fucosylation in cancer biology

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Microheterogeneity of rat alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2810%2978006-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0076-6879(10)78006-X

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37785212&oldid=1728276954"